Ann Kennedy

ANN KENNEDY -- Richard Chamberlain Professor of Research Oncology and professor, department of radiation oncology, University of Pennsylvania School of Medicine, Philadelphia "THE SCIENTIST supplies us with crucial information that affects our daily lives as scientists-the sort of information that's not available in the peer-reviewed scientific literature." -- Ann Kennedy Ann Kennedy has received numerous honors for research as a radiation/cancer biologist, including the prestigious Research

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ANN KENNEDY -- Richard Chamberlain Professor of Research Oncology and professor, department of radiation oncology, University of Pennsylvania School of Medicine, Philadelphia

A. Kennedy "THE SCIENTIST supplies us with crucial information that affects our daily lives as scientists-the sort of information that's not available in the peer-reviewed scientific literature." -- Ann Kennedy

Ann Kennedy has received numerous honors for research as a radiation/cancer biologist, including the prestigious Research Award from the Radiation Research Society. While the award has been given more than a dozen times, Kennedy is only the second American researcher to have received it.

Much of her recent work in cancer prevention has been on the soybean-derived protease inhibitor called the Bowman-Birk inhibitor. This protease inhibitor is now being evaluated as a human cancer-preventive agent as well as a potential therapeutic agent for a number of other diseases.

Outside of the lab, Kennedy has concerns about the future of funding ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies